Webinar: Why Patient-Specific Insulin Dosing Matters. Watch for free today!
Blog
The Patient Safety Movement Pledge to Improve Prevention of Severe Hypoglycemia: Part 3
In part 2 of this series dedicated to the Patient Safety Movement Pledge, we educated our readers on the performance gap and explained that hospitals and healthcare systems will have to take action in specific leadership, practice, and technology plans in order to predict and prevent severe hypoglycemia episodes. Below are the suggested plans.
Leadership Plan
- Must include the fundamentals of change outlined in the National Quality Forum Safe Practices
- Hospital governance must understand the performance gaps in their own healthcare system and must close these gaps with a comprehensive approach
- Hospitals should set a goal date including measurable quality indicators and milestones
- The hospital’s budget for the plan needs to be evaluated by the governance boards
- The plan needs to be endorsed by clinical and safety leadership
Practice Plan
- Create a multidisciplinary team dedicated to glycemic management and best practices
- Develop a systematic approach to reducing severe hypoglycemia by identifying events and prioritizing them in order to raise institutional awareness and educate the hospital staff
- Implement Foundational Best Practices and “Just Do Its”
- Investigate glycemic events and collect causative factors such as insulin stacking and insufficient glycose monitoring
- Share strategies and implement informed interventions on target floors and patients.
Technology Plan
- Implement for insulin therapy recommendation
- Implement real-time surveillance method for informatics alerts
- Implement an automated hypoglycemia event analysis tool
- Implement point-of-care blood glucose monitoring and reporting systems to include quality insurance reports
- Implement automated triggers for most common causative factors of hypoglycemia
- Implement a results dashboard for each nursing unit within the hospital to resolve hypoglycemic events
- Set restrictions for prescribing insulin to only specialists
Related posts

Blog
Celebrating Nurses Who Lead: Why Nurse-Led Training Sets the Standard
Celebrating Nurses Who Lead: Why Nurse-Led Training Sets the Standard
Honoring Nurse Educators for National Nurses Week As we celebrate National Nurses Week, we're shining a light on the incredible work nurses do every day—not just at the bedside, but also as educators, leaders, and change agents. At Monarch Medical ...

Blog
Every 30 Seconds: The Decision Pressure Nurses Face
Every 30 Seconds: The Decision Pressure Nurses Face
Honoring Nurses Week 2025 Every May, we take a moment to celebrate the nurses who are the backbone of our healthcare system. But their impact isn't just something to recognize once a year - it's felt every second of every ...

News
Monarch Medical Technologies Announces FDA Clearance of EndoTool IV 3.1 with Dosing Mode For Hyperglycemic Crisis Management
Monarch Medical Technologies Announces FDA Clearance of EndoTool IV 3.1 with Dosing Mode For Hyperglycemic Crisis Management
Strengthening Hospital Response to Hyperglycemic Crisis: EndoTool may be used in the treatment of hyperglycemic crises, including conditions such as Euglycemic DKA (EuDKA), DKA, and HHNK. Monarch Medical Technologies, the only patient-specific insulin dosing solution for hospitals, today announced FDA ...
Get in Touch
Ready to get started?
Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.
"*" indicates required fields